Moderna
MRNA
#290
Rank
โ‚ฌ71.92 B
Marketcap
177,76ย โ‚ฌ
Share price
-2.17%
Change (1 day)
763.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): -6,89ย โ‚ฌ

According to Moderna 's latest financial reports the company's current EPS (TTM) is -7,28ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -6,63ย โ‚ฌ an increase over its 2024 EPS that were of -8,46ย โ‚ฌ.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-6,89ย โ‚ฌ4.03%
2025-6,63ย โ‚ฌ-21.66%
2024-8,46ย โ‚ฌ-25.04%
2023-11,29ย โ‚ฌ-158.62%
202219,25ย โ‚ฌ-30.25%
202127,60ย โ‚ฌ-1660.82%
2020-1,77ย โ‚ฌ25.32%
2019-1,41ย โ‚ฌ36.87%
2018-1,03ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,79ย โ‚ฌ-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
0,91ย โ‚ฌ-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-0,67ย โ‚ฌ-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,85ย โ‚ฌ-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
18,06ย โ‚ฌ-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-3,04ย โ‚ฌ-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA